Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

    Mar 5, 2025, 08:14 AM by
    Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.
    Full story
  • High-Performance Computing in the AI Era: Challenges and Future Prospects

    Mar 5, 2025, 01:00 AM by User Not Found
    Bio-IT World| In an era where artificial intelligence (AI) dominates discussions in technology, high-performance computing (HPC) remains the backbone of scientific discovery and enterprise research. Despite its critical role, HPC often operates in the background, much like electricity—only noticed when it fails. On the latest Trends from the Trenches Podcast, Dirk Petersen, Director of the Supercomputing Center at Oregon State University, shared his insights on the evolving role of HPC and its integration into AI-driven research.
    Full story
  • AI to Democratize Access to Cheap, High-Throughput Cardiotoxicity Testing

    Mar 4, 2025, 01:00 AM by User Not Found
    Bio-IT World| Researchers have trained an artificial intelligence (AI) model to reconstruct the electrical signals inside of heart cells based on recordings taken from outside those cells, opening the possibility of cheap, high-yielding cardiotoxicity testing using commercially available microelectrode arrays. The hope is that the U.S. Food and Drug Administration (FDA) will allow the tool to be used in lieu of inserting pipettes into cells to record signaling changes with the addition of a drug, which is both costly and cumbersome to do at scale.
    Full story
  • Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

    Feb 28, 2025, 08:10 AM by
    Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.
    Full story
  • The False Dichotomy of Short Reads vs. Long Reads

    Feb 28, 2025, 01:00 AM by User Not Found
    Bio-IT World| The rate of evolution of DNA sequencing technologies since the introduction of the Sanger method in the 1970s has been astounding. It’s just over 20 years since the publication of the first draft human genome and today, technologies can deliver that same information for as little as $100.
    Full story
  • eClinical Solutions Details Strong 2024 and Announces New Products Aimed at Reducing Cycle Times for Biopharma

    Feb 27, 2025, 10:28 AM by
    Company prioritizes efficiency through innovation with new embedded AI and automation platform capabilities, including a GenAI-Powered Chatbot and Clean Progress Tracking
    Full story
  • Biocair Announces Further Expansion in the APAC Region As Part of Global Growth Strategy

    Feb 27, 2025, 10:28 AM by
    Biocair, an established global leader in life science logistics, announces the expansion of its operations with the opening of a new office in Chengdu, Sichuan Province, China.
    Full story
  • RNA in Oncology Research, Ultima Genomics Commercially Launches Platform, More

    Feb 27, 2025, 09:20 AM by User Not Found
    Bio-IT World| InfoBionic.Ai’s MoMe ARC delivers real-time cardiac insights, empowering physicians to improve patient outcomes; Ultima Genomics announced the commercial launch of UG 100 Solaris; and more.
    Full story
  • Follow the Money: 3D Spatial Biology, AI-Powered Imaging Biomarkers, More

    Feb 26, 2025, 08:13 AM by User Not Found
    Bio-IT World| Stellaromics commercializes their 3D spatial biology platform, Pyxa; Latent Labs’ AI platform shows promising potential to open new paths to personalized medicines; and more.
    Full story
  • Oxford Nanopore expands compatibility with 10x Genomics to unlock deeper insights in single-cell transcriptomics

    Feb 25, 2025, 08:07 AM by
    Oxford Nanopore has expanded its collaboration with 10x Genomics to help improve single-cell transcriptomics research.
    Full story
  • Vector Laboratories Announces the Appointment of Ashley Scholz as Vice President of Marketing

    Feb 25, 2025, 08:07 AM by
    Vector Laboratories has appointed Ashley Scholz as its new Vice President of Marketing. Ashley brings 16+ years of experience in medical devices, cancer diagnostics, and molecular diagnostics, most recently leading marketing at W.L. Gore & Associates.
    Full story
  • Sphere Fluidics rebrands to Sphere Bio

    Feb 25, 2025, 08:07 AM by
    Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.
    Full story
  • Qureight core imaging platform deployed within Vicore Phase 2b ASPIRE study of buloxibutid for IPF

    Feb 24, 2025, 08:06 AM by
    Qureight Ltd and Vicore Pharma today announce the implementation of Qureight’s Core Imaging Platform within the global Phase 2b ASPIRE trial investigating buloxibutid in patients with idiopathic pulmonary fibrosis (IPF).
    Full story
  • VECTOR LABORATORIES ANNOUNCES PARTNERSHIP WITH BRITISH BIOTECH INNOVATOR ETCEMBLY

    Feb 21, 2025, 08:19 AM by
    Vector Laboratories and Etcembly announce a collaboration to accelerate recombinant antibody therapeutic development. The collaboration combines Vector’s antibody expertise with AI-driven insights from Etcembly’s award-nominated platform.
    Full story
  • Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth

    Feb 21, 2025, 08:19 AM by
    Full story
  • ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health

    Feb 20, 2025, 08:27 AM by
    ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.
    Full story
  • ResultsCX Rises to ‘Innovator’ Status in Avasant’s CX Center Business Process Transformation RadarView™ Assessment

    Feb 20, 2025, 08:27 AM by
    Full story
  • Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform

    Feb 20, 2025, 08:27 AM by
    Full story
  • Eli Lilly’s CISO Andrea Abell on Safeguarding Innovation in Pharma

    Feb 20, 2025, 01:00 AM by User Not Found
    Bio-IT World| Earlier this week at the ViVE conference in Nashville, Tenn., Bio-IT World editor, Allison Proffitt, sat down with Andrea Abell, Eli Lilly’s Chief Information Security Officer (CISO), whose mission is to protect the integrity of pharmaceutical research from inception to patient delivery. Together they discussed the critical role cybersecurity plays in Lilly’s broader goal of bringing life-changing medicines to market.
    Full story
  • Illumina’s New Spatial Products

    Feb 19, 2025, 12:45 PM by User Not Found
    Bio-IT World| Today, Illumina announced a new spatial technology program of Illumina sequencers and a multimodal analysis platform. The company also announced a collaboration with the Broad Institute on spatial transcriptomics. Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity.
    Full story
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9 (current)
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy